FTC Takes Action Against CVS, Cigna, and UnitedHealth Over Allegations of Abuse in Pharmaceutical Middleman Role

In a significant move that could reshape the landscape of the pharmaceutical industry, the Federal Trade Commission (FTC) has launched an investigation into three prominent players—CVS Health, Cigna, and UnitedHealth Group. The agency accuses these companies of exploiting their positions as pharmacy benefit managers (PBMs) and engaging in practices that allegedly harm consumers and distort competition.

Continue reading